未登录

E

Elaine T. Alarid

University of Wisconsin System

H指数:32

被引数:4,107

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Differential regulation of estrogen-inducible proteolysis and transcription by the estrogen receptor α N terminus

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-27120

OAAI

Repression of ESR1 through Actions of Estrogen Receptor Alpha and Sin3A at the Proximal Promoter

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-2186

OAAI

Regulation of Estrogen Receptor α N-Terminus Conformation and Function by Peptidyl Prolyl Isomerase Pin1

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-2074

OAAI

The Phosphorylated Estrogen Receptor α (ER) Cistrome Identifies a Subset of Active Enhancers Enriched for Direct ER-DNA Binding and the Transcription Factor GRHL2

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-0327

OAAI

GRHL2 Enhances Phosphorylated Estrogen Receptor (ER) Chromatin Binding and Regulates ER-Mediated Transcriptional Activation and Repression

GRHL2增强磷酸化雌激素受体 (ER) 染色质结合并调节ER介导的转录激活和抑制

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-02-248

OA

Progesterone Receptor-Mediated Regulation of Cellular Glucose and 18F-Fluorodeoxyglucose Uptake in Breast Cancer

JOURNAL OF THE ENDOCRINE SOCIETY

IF3.1

2022-12-031

OAAI

Selective pressure of endocrine therapy activates the integrated stress response through NFκB signaling in a subpopulation of ER positive breast cancer cells

BREAST CANCER RESEARCH

IF5.6

2022-03-098

OAAI

Identification of novel ER and ER-NFκB driven stem-like cell populations in ER plus breast cancer

CANCER RESEARCH

IF16.6

2022-02-150

PRE

Collagen I Fibrous Substrates Modulate the Proliferation and Secretome of Estrogen Receptor-Positive Breast Tumor Cells in a Hormone-Restricted Microenvironment

ACS BIOMATERIALS SCIENCE & ENGINEERING

IF5.5

2021-03-109

OAAI

The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor-Positive Breast Cancers

MOLECULAR CANCER RESEARCH

IF4.7

2020-07-0233

OAAI

Bone Marrow Stromal Cells Transcriptionally Repress ESR1 but Cannot Overcome Constitutive ESR1 Mutant Activity

IF3.3

2019-07-257

OAAI

Anisotropy of collagen I matrix influences therapeutic response and secretome of Luminal A cells

CANCER RESEARCH

IF16.6

2019-07-010

PRE

Mammary adipose stromal cells derived from obese women reduce sensitivity to the aromatase inhibitor anastrazole in an organotypic breast model

IF4.2

2019-04-1928

OAAI

Grainyhead-like Protein 2: The Emerging Role in Hormone-Dependent Cancers and Epigenetics

IF3.3

2019-04-0826

OAAI

NFκB pathway activation is a key determinant of tamoxifen tolerance and recurrence in breast cancer

CANCER RESEARCH

IF16.6

2018-07-010

PRE

Mammary fibroblasts reduce apoptosis and speed estrogen-induced hyperplasia in an organotypic MCF7-derived duct model

SCIENTIFIC REPORTS

IF3.9

2018-05-0846

OAAI

Personalized in vitro cancer models to predict therapeutic response: Challenges and a framework for improvement

PHARMACOLOGY & THERAPEUTICS

IF12.5

2016-09-0164

OAAI

Transitions from mono- to co- to tri-culture uniquely affect gene expression in breast cancer, stromal, and immune compartments

BIOMEDICAL MICRODEVICES

IF3.3

2016-07-1819

OAAI

Ubiquitylation of nuclear receptors: new linkages and therapeutic implications

JOURNAL OF MOLECULAR ENDOCRINOLOGY

IF3.8

2015-05-0541

OAAI

Peptidylprolyl Isomerase Pin1 Directly Enhances the DNA Binding Functions of Estrogen Receptor α

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2015-05-0119

OAAI